新京报贝壳财经讯（记者韦博雅）12月31日，上纬新材董事长彭志辉（稚晖君）发布了全球首款全身力 控小尺寸人形机器人启元Q1，这意味着公司以"上纬启元"的品牌正式布局个人机器人赛道。据彭志辉 介绍，启元Q1身高仅0.8米，是将全尺寸人形机器人能力压缩至书包大小的产品。其核心突破在于实现 了QDD准直驱关节的极限微型化，比鸡蛋还小的关节模组承载着完整力控与高响应能力。同时，该机 器人SDK（软件开发工具包）、HDK（硬件开发工具包）完全开放，支持第三方接口与扩展模块。 校对 柳宝庆 编辑 岳彩周 ...

新 京 报 √ 贝壳财经 日同日 联网 方 China Internet Developme 2025中国向上·新席朱锋 胜阳未来产业 t无要买领跑者 跨境电商 =21 per 打卡北京小巨人 北京数字经济企业出海创新服务基 部总经理李导龙: G 出海基地正在通过构建 八大核心服务'体系, 打造'政策创新、生态服 海外订单、合规监 餐、 管'四大高地和外向型产 业集群助力公用海。 （中国互联网发展基金会中国正能量网络传播专项基金支持） 全球贸易变局下，北京外贸以创新为破局密钥，践行 "十五五" 贸易强国部署。京东、抖音、值得买科技等企业发力跨境电商，借助 AI、内容生态优化出海 全链路；北京数字经济出海创新服务基地搭建 "1+3+N" 生态，提供一站式出海支持。同时，企业深化内外贸一体化，通过 "出口转内销" 等计划筑牢发展屏 障。政策护航与数字赋能叠加，北京外贸从传统代工向 "自主研发 + 全球品牌" 转型，成为双循环格局下高质量发展的重要支撑。 ...

新 京 报 影 贝壳财经 打卡北京小巨人 延动力创始人姜哲源: tt 不可否认人形机器人行业可能 确实还在泡沫过程中,但我们 相信,机器人行业是难而正 确、长期正确的一个行业。 （中国互联网发展基金会中国正能量网络传播专项基金支持） 在中央经济工作会议部署下，北京人形机器人产业正通过硬核技术与场景落地，成为"十五五"规划中培育新增长点的生动实践。其标志性事件是2025年8 月，由北京团队助力的人形机器人在国家速滑馆举行的世界杯决赛中远射破门，夺得冠军。 ...

站在"十五五"新程待启的关键时点，如何看待2026年的经济形势？2026年经济工作怎么干？新京报贝壳财经推出《看2026：十五五·启新程》专题报道，汇 聚监管部门、知名学者和领军企业家，解读政策脉络，洞察趋势变化。 对于企业而言，针对中央经济工作会议提出的持续扩大内需等议题会有哪些举措？2026年有哪些战略发展目标？新京报贝壳财经记者就此采访了天智航董事 会秘书黄军辉。 新京报贝壳财经：2026年，公司在业绩增长、产品创新、业务线等方面有何战略发展目标？ 黄军辉：业绩增长目标是力争实现营业收入与市场占有率的稳步提升，保持在中国骨科手术机器人市场的领先地位。通过市场下沉与海外探索，寻求新的增 长曲线。同时，持续优化成本结构，提升管理效率，追求高质量、可持续的盈利增长，以更好的业绩回报广大投资者。 产品创新目标是在现有"天玑"平台基础上，推出更具智能化、模块化特点的骨科手术机器人系统。在关键技术上取得突破，提升自主规划能力、集成更先进 的影像融合与实时导航技术，拓展公司的技术边界与应用领域，保持技术领先优势。 业务线发展目标是核心业务线（骨科手术机器人销售与服务）将持续深化，强化从设备到服务的全链条价值。探索基于 ...

站在"十五五"新程待启的关键时点，如何看待2026年的经济形势？2026年经济工作怎么干？新京报贝壳财经推出《看2026：十五五·启新程》专题报道，汇 聚监管部门、知名学者和领军企业家，解读政策脉络，洞察趋势变化。 对于企业而言，针对中央经济工作会议提出的持续扩大内需等议题会有哪些举措？2026年有哪些战略发展目标？新京报贝壳财经记者就此采访了强联智创创 始人、董事长、总经理秦岚。 围绕高端医疗装备对可靠性、稳定性和一致性的严格要求，强联智创将把产品创新与制造体系建设同步推进。公司将依托神经血管疾病智能诊疗装备智能产 线建设项目，系统整合核心算法、关键部件、仿真模型与先进制造工艺，推动研发成果在中试验证、工艺优化和规模化生产中的高效转化。通过智能化、模 块化和标准化的生产体系建设，不断提升产品迭代效率和交付能力，形成支撑企业持续增长的高质量供给基础。 在已有技术成果和产品体系基础上，强联智创将进一步挖掘存量资源的综合价值。依托智能产线和既有产品平台，公司将加强与国家神经疾病医学中心、重 点医院、高校及科研机构的协同合作，推动产品在临床应用、教学培训和科研验证中的多场景复用，通过真实世界数据反哺产品优化和工艺改 ...

Core Viewpoint - The article discusses the strategic initiatives and goals of the company Mo Xiaoxian for 2026, focusing on sustainable growth, product innovation, and business line collaboration in response to the central economic work meeting's emphasis on expanding domestic demand and optimizing supply [2][7]. Group 1: Strategic Initiatives - Mo Xiaoxian will focus on "precise supply, systematic innovation, and agile organization" as the three pillars to drive sustainable growth and product differentiation [2][7]. - The company plans to enhance R&D investments to align with health-oriented and scenario-based consumption trends, emphasizing clean labels, high-quality raw materials, and low glycemic index (GI) products [4][5]. - A flexible supply chain will be established to optimize capacity layout and inventory turnover, allowing for quick responses to regional market preferences and avoiding resource idleness [5][6]. Group 2: Market and Product Development - The company aims to deepen channel penetration and adapt to various consumption scenarios to improve overall revenue and turnover efficiency [7]. - Mo Xiaoxian will implement a user co-creation mechanism to develop localized and emotional product matrices, focusing on health and personalization trends [7][8]. - The introduction of a "regional specialty flavor plan" will involve collaboration with regional users and channel partners to enhance product development through user participation [8]. Group 3: Organizational Structure and Digitalization - A cross-departmental collaboration system will be established to enhance digital capabilities and ensure the effective implementation of strategies [8]. - The formation of a "channel-product-user" triangular collaboration group will facilitate regular market insights and demand feedback mechanisms [8].

北京祥龙物流（集团）有限公司党委副书记、董事、总经理杨林飞。受访者供图 新京报贝壳财经：中央经济工作会议提出持续扩大内需、优化供给，做优增量、盘活存量，因地制宜发展新质生产力，对此，祥龙物流有哪些具体举措？ 杨林飞：祥龙物流根据中央经济工作会议精神，结合企业主业情况，有以下举措： 站在"十五五"新程待启的关键时点，如何看待2026年的经济形势？2026年经济工作怎么干？新京报贝壳财经推出《看2026：十五五·启新程》专题报道，汇 聚监管部门、知名学者和领军企业家，解读政策脉络，洞察趋势变化。2026，我们携手出发。 对于企业而言，针对中央经济工作会议提出的持续扩大内需等议题会有哪些举措？2026年有哪些战略发展目标？新京报贝壳财经记者就此采访了北京祥龙物 流（集团）有限公司党委副书记、董事、总经理杨林飞，他表示，祥龙物流将以技术驱动服务创新，培育绿色、高效的物流新业态。 C Partis di � 8 2 � 2017-02-25 r and the later per 19 一是服务扩大内需，确保物流供应链畅通。强化干线运输与城市配送网络，打通民生保障物资上行与下行双向通道。通过建设区域性集散中心，提升对民 ...

Group 1 - The central economic work meeting emphasizes the need to continuously expand domestic demand and optimize supply, which will influence the company's strategic initiatives [2][3]. - The company aims to create a fully mobile commercial space, focusing on two main sectors: after-market services for commercial/passenger vehicles and consumer services [3][4]. - In 2026, the company plans to enhance market support for its service offerings, reduce operational costs for partner businesses, and invest in research and development to upgrade mobile maintenance service vehicles [4][6]. Group 2 - The company has set strategic development goals for 2026, including performance growth, product innovation, and business line expansion [5]. - Product innovation will involve upgrading existing products and introducing new specialized service vehicles, enhancing features such as automatic sensing and 360-degree monitoring [6]. - The company will focus on expanding its domestic after-market services for commercial/passenger vehicles, developing consumer service partnerships, and initiating overseas business channels in Central Asia, West Asia, Southeast Asia, and the Middle East [7].

Core Insights - The article discusses the economic outlook for 2026 and the strategic development goals of companies in response to the central economic work conference's emphasis on expanding domestic demand and optimizing supply [1][2]. Company Developments - In 2025, the company will celebrate its 10th anniversary, marking a significant milestone with multiple "China's first" achievements in the biopharmaceutical sector [7]. - The company has entered into a major collaboration with Zenas worth over $2 billion, setting a record for external licensing in China's small molecule field [7]. - The company has achieved profitability two years ahead of schedule due to significant commercial developments and partnerships [7]. Product Innovations - The company has received approval for two innovative drugs: the first CD19 monoclonal antibody for treating diffuse large B-cell lymphoma (DLBCL) and the first domestically developed next-generation TRK inhibitor [7][8]. - The company is advancing multiple clinical trials for its BCL2 inhibitor Mesutoclax, which has shown significant efficacy in treating various blood cancers [8]. - The company is also progressing with its BTK inhibitor, which has entered phase III clinical trials for several indications, including systemic lupus erythematosus (SLE) and immune thrombocytopenic purpura (ITP) [8]. Strategic Goals for 2026 - The company aims to launch five to six innovative drugs and develop five to ten differentiated clinical candidates, focusing on global expansion and innovation [9][10]. - The company plans to enhance its overseas team capabilities and accelerate its globalization efforts, targeting three to four products for global markets [10]. - The company will maintain a strong entrepreneurial spirit and agility in execution to navigate uncertainties and drive rapid growth [10].

Core Insights - The demand for Beijing's office market is recovering more than expected, with a significant reduction in vacancy rates by year-end 2025 [1] - The net absorption of Grade A office space in Beijing reached 330,000 square meters in 2025, marking the second consecutive year of over 300,000 square meters of absorption [1] - The new supply of Grade A office space in Beijing for 2025 was only 188,000 square meters, leading to a favorable balance between limited supply and steady demand, resulting in a vacancy rate decrease to 19.2%, down approximately 1.5 percentage points year-on-year [1] Market Performance - The net absorption of Grade A office space in 2025 was 333,000 square meters, compared to 312,000 square meters in 2024, while Grade B office space saw a net absorption of 94,000 square meters, a significant increase from a negative absorption of 32,000 square meters in 2024 [2] - The overall vacancy rate for the office market in 2025 was 20.7%, with Grade A offices at 19.2% and Grade B offices at 19.6% [2] - The average effective rent for Grade A offices decreased to 222 RMB per square meter per month, reflecting an 11.5% year-on-year decline, although the rate of decline has slowed compared to the previous year [2] Submarket Highlights - The Zhongguancun area emerged as the standout performer in 2025, with a net absorption of over 176,000 square meters, accounting for 53% of the city's total, marking a peak not seen in nearly 20 years [3] - The growth in demand in Zhongguancun is driven by the rise of new productivity enterprises and the concentration of industrial benefits, positioning it as a key engine for the recovery of Beijing's office market [3] - There is a notable disparity in performance between core and non-core areas, with average rents in mature core submarkets declining by over 10% year-on-year, indicating a competitive landscape across different asset classes and market segments [3] Future Outlook - The macroeconomic demand remains a systemic issue that could hinder the sustained recovery of the office market, with potential tenant downsizing and relocations expected in 2026 [4] - The supply-demand mismatch is anticipated to become more pronounced, with over 700,000 square meters of new supply expected in core markets in 2026, while demand is concentrated in western submarkets [4] - The majority of new projects entering the market in 2026 will be located in eastern submarkets, potentially intensifying competition in those areas [4]